- Consistently positive technical signals over the last month
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Established player in the Healthcare sector
Adial Pharmaceuticals Inc. stock upgraded to Buy Candidate
(Updated on Jul 13, 2026)
The Adial Pharmaceuticals Inc. stock price gained 1.80% on the last trading day (Monday, 13th Jul 2026), rising from $2.78 to $2.83. During the last trading day the stock fluctuated 8.48% from a day low at $2.71 to a day high of $2.94. The price has risen in 5 of the last 10 days and is up by 10.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 53 thousand shares were bought and sold for approximately $149.04 thousand.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 88.81% during the next 3 months and, with a 90% probability hold a price between $4.54 and $6.59 at the end of this 3-month period.
ADIL Signals & Forecast
The Adial Pharmaceuticals Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.86. On a fall, the stock will find some support from the long-term average at approximately $2.56. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Adial Pharmaceuticals Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 12, 2026, and so far it has fallen -5.03%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Adial Pharmaceuticals Inc. stock
Adial Pharmaceuticals Inc. finds support from accumulated volume at $2.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.230 between high and low, or 8.48%. For the last week, the stock has had daily average volatility of 6.14%.
Our recommended stop-loss: $2.72 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 19 days ago.)
Trading Expectations (ADIL) For The Upcoming Trading Day Of Tuesday 14th
For the upcoming trading day on Tuesday, 14th we expect Adial Pharmaceuticals Inc. to open at $2.83, and during the day (based on 14 day Average True Range), to move between $2.69 and $2.97, which gives a possible trading interval of +/-$0.273 (+/-10.14%) up or down from last closing price. If Adial Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 10.14% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.85 (0.71%) than the support at $2.75 (2.83%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Adial Pharmaceuticals Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Adial Pharmaceuticals Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
2.398
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 14, 2026 - $2.83 ( 0.120%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ADIL Performance
Trading levels for ADIL
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.06 | 8.00% |
| R2 | 2.97 | 4.90% |
| R1 | 2.91 | 2.98% |
| Price | 2.83 | |
| S1 | 2.74 | -3.22% |
| S2 | 2.68 | -5.14% |
| S3 | 2.60 | -8.24% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.98 | 5.30% |
| R2 | 2.90 | 2.47% |
| R1 | 2.85 | 0.707% |
| Price | 2.83 | |
| S1 | 2.75 | -2.83% |
| S2 | 2.54 | -10.25% |
| S3 | 2.35 | -16.96% |
FAQ
Click here for our free guide on how to buy Adial Pharmaceuticals Inc. Stock.
Buy ADIL